NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/20/2020
Back to search
Official data from USPTO
OZURDEX PATIENT ASSISTANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OZURDEX PATIENT ASSISTANCE
ST13
US500000077761199Class
44
Filing
77761199
Registration
3779440
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
05/20/2020
Trademark type
Word
Nice classes
44
Filing date
06/16/2009
Registration date
04/20/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2020
Last transaction
05/20/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/16/2009
First use in commerce
09/01/2009
Drawing code
4
Owner type
03
Owner location
Irvine, CA, US
Examiner
LORENZO, GEORGE M
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Allergan, Inc.
Representatives
Allergan, Inc.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Patient assistance programs that provide medical drugs to help patients with insufficient resources get treatment at little or no cost to the patient
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/20/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/20/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/20/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
03/13/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/20/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/01/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/01/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/01/2015
E815
TEAS SECTION 8 & 15 RECEIVED
04/20/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/20/2015
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/20/2015
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/06/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2010
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/27/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
04/20/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/12/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/11/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/28/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/28/2010
IUAF
USE AMENDMENT FILED
01/29/2010
EISU
TEAS STATEMENT OF USE RECEIVED
01/29/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
01/19/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/27/2009
PUBO
PUBLISHED FOR OPPOSITION
10/27/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/18/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/17/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
09/15/2009
ALIE
ASSIGNED TO LIE
09/15/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/15/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
09/15/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/15/2009
DOCK
ASSIGNED TO EXAMINER
09/15/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/19/2009
NWAP
NEW APPLICATION ENTERED
06/19/2009
Continuous trademark protection
Get notified about every new filing that threatens OZURDEX PATIENT ASSISTANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.